Top Markets
Coin of the day
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Rank in Stocks #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Share Price
$0.14966934
Last synced: 2026-08-14
Market Cap
$3.02M
Change (1 day)
3.72%
Change (1 year)
-93.70%
Country
SE
Trade Guard Therapeutics International AB (publ) (GUARD)

Category

EPS for Guard Therapeutics International AB (publ) (GUARD)
EPS as of 2026 TTM: 0
According to Guard Therapeutics International AB (publ) latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Guard Therapeutics International AB (publ) from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE